1990
DOI: 10.1002/1097-0142(19900501)65:9<1903::aid-cncr2820650905>3.0.co;2-#
|View full text |Cite
|
Sign up to set email alerts
|

Testicular dysfunction after cyclophosphamide‐vincristine‐procarbazine‐prednisolone chemotherapy for advanced hodgkin's disease a long‐term follow‐up study

Abstract: Gonadal functions were evaluated in 92 male patients after treatment for advanced Hodgkin's disease. The patients received six to ten cycles of cyclophosphamide, vincristine, procarbazine, and prednisolone (COPP) chemotherapy. All patients were in remission and were followed for 1 to 17 years (median, 6). Testicular atrophy was noticed in 89 (96.7%) patients. All patients remained azoospermic during the period of follow-up. The testosterone levels did not differ before and after treatment. The follicle stimula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
26
0
3

Year Published

1992
1992
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(32 citation statements)
references
References 17 publications
3
26
0
3
Order By: Relevance
“…The COPP regimen (cyclophosphamide, vincristine, procarbazine, and prednisolone), which includes the gonadotoxic agent cyclophosphamide in addition to procarbazine, is associated with even more marked gonadal dysfunction. Charak et al [11] found azoospermia in all 92 patients following treatment with six or more cycles of COPP, along with significant rises in gonadotrophin levels compared with pretreatment values. The median followup in this study was 6 years, with 17% of patients having been treated more than 10 years previously, suggesting that germinal epithelial failure is likely to be permanent.…”
Section: Chemotherapysupporting
confidence: 89%
See 1 more Smart Citation
“…The COPP regimen (cyclophosphamide, vincristine, procarbazine, and prednisolone), which includes the gonadotoxic agent cyclophosphamide in addition to procarbazine, is associated with even more marked gonadal dysfunction. Charak et al [11] found azoospermia in all 92 patients following treatment with six or more cycles of COPP, along with significant rises in gonadotrophin levels compared with pretreatment values. The median followup in this study was 6 years, with 17% of patients having been treated more than 10 years previously, suggesting that germinal epithelial failure is likely to be permanent.…”
Section: Chemotherapysupporting
confidence: 89%
“…Following chemotherapy for Hodgkin's disease with procarbazine-containing regimens and high-dose radiotherapy, recovery to oligo-or normospermia is uncommon. Testicular biopsies taken after standard chemotherapy (MVPP and COPP) for Hodgkin's disease have shown complete germinal aplasia with a Sertoli-cell only pattern [6,11,33,48,49]. Recent reports have been made of the isolation of mature sperm in the testicular parenchyma of some men with biopsy evidence of Sertolicell only, suggesting that even in this situation there may be small foci of spermatogenesis [50].…”
Section: Hormonal Manipulationmentioning
confidence: 97%
“…DNA damage rates in sperm are higher in infertile individuals (Irvine et al 2000), patients subjected to cancer therapies (Charak et al 1990, Kenney et al 2001, men who smoke (Zenzes et al 1999, Zenzes 2000 and also possibly in older men (Wyrobek et al 2006). Concerns have been expressed that using sperm with damaged DNA for intracytoplasmic sperm injection (ICSI) could have a long-term effect on the health of the children born to subfertile couples (Gosden et al 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Following treatment more than 91% continued to have azoospermia at a follow-up of five years, which is similar to other studies 9,12 (Table 3). The effect of cyclophosphamide and procarbazine combination on sperm count and hormone levels (FSH) was significant.…”
Section: Valuesmentioning
confidence: 99%